Clinicopathologic Characteristics of Papillary Microcarcinoma in the Elderly
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Objectives: Older patients show more aggressive features in papillary thyroid carcinoma (PTC). However, data about clinicopathologic features of older patients in papillary thyroid microcarcinoma (PTMC) are limited. Presently, we investigated the difference of clinicopathologic features in PTMC according to age. Materials and Methods: A total of 820 PTMC patients (82 males, 10%; 738 females, 90%) who underwent total thyroidectomy at Pusan National University Hospital were enrolled. The patients were divided into three age groups: group 1 (44 years or younger, n=230), group 2 (45-64 years, n=513), and group 3 (65 years or older, n=77). Results: Extrathyroidal extension was 33% in group 1, 32.2% in group 2, and 31.2% in group 3 (p=0.948). There was no significant difference of lymph node metastasis between the groups: N0 (59.1% vs. 67.8% vs. 70.1%), N1a (37.4% vs. 28.8% vs. 26%), and N1b (3.5% vs. 3.3% vs. 3.9%) (p=0.159). Of the 820 patients, 526 (64.1%) were diagnosed as early stage (stage I, II) PTMC and 294 (35.9%) were diagnosed as advanced stage (stage III, IV) PTMC. The proportion of patients with each stage was significantly different between the groups (p＜0.001). However, there was no significantly difference in the stage over 45 years old. Of the 820 patients, 517 were evaluated BRAFV600E mutation. There was no difference in prevalence between each group. Conclusion: There was no statistically significant difference of clinicopathologic features between the groups, indicating that old age itself was not associated with unfavorable clinicopathologic features in PTMC.
Abstract
Background and Objectives: Older patients show more aggressive features in papillary thyroid carcinoma (PTC). However, data about clinicopathologic features of older patients in papillary thyroid microcarcinoma (PTMC) are limited. Presently, we investigated the difference of clinicopathologic features in PTMC according to age. Materials and Methods: A total of 820 PTMC patients (82 males, 10%; 738 females, 90%) who underwent total thyroidectomy at Pusan National University Hospital were enrolled. The patients were divided into three age groups: group 1 (44 years or younger, n=230), group 2 (45-64 years, n=513), and group 3 (65 years or older, n=77). Results: Extrathyroidal extension was 33% in group 1, 32.2% in group 2, and 31.2% in group 3 (p=0.948). There was no significant difference of lymph node metastasis between the groups: N0 (59.1% vs. 67.8% vs. 70.1%), N1a (37.4% vs. 28.8% vs. 26%), and N1b (3.5% vs. 3.3% vs. 3.9%) (p=0.159). Of the 820 patients, 526 (64.1%) were diagnosed as early stage (stage I, II) PTMC and 294 (35.9%) were diagnosed as advanced stage (stage III, IV) PTMC. The proportion of patients with each stage was significantly different between the groups (p＜0.001). However, there was no significantly difference in the stage over 45 years old. Of the 820 patients, 517 were evaluated BRAFV600E mutation. There was no difference in prevalence between each group. Conclusion: There was no statistically significant difference of clinicopathologic features between the groups, indicating that old age itself was not associated with unfavorable clinicopathologic features in PTMC.
참고문헌 (30)
- Vasileiadis I, "Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients", Eur J Clin Invest, 42(6), pp.657~664 (2012)
- 이남섭, "갑상선 미세유두상암에서 림프절 전이의 위험인자", 대한외과학회지, 78(2), pp.82~86 (2010), 대한외과학회
- Sobin LH, "International Union Against Cancer. TNM classification of malignant tumours" (2010), Wiley-Blackwell
- Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002", JAMA, 295(18), pp.2164~2167 (2006)
- Lo CY, "Papillary microcarcinoma: is there any difference between clinically overt and occult tumors?", World J Surg, 30(5), pp.759~766 (2006)
- Ito Y, "An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid", Thyroid, 13(4), pp.381~387 (2003)
- Chow SM, "Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality", Cancer, 98(1), pp.31~40 (2003)
- Yi KH, "Revised Korean Thyroid Association Management Guidelines for patients with thyroid nodules and thyroid cancer", Korean J Otorhinolaryngol-Head Neck Surg, 54(1), pp.8~36 (2011)
- Gilliland FD, "Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991", Cancer, 79(3), pp.564~573 (1997)
- Cappelli C, "Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono- institutional experience", J Surg Oncol, 95(7), pp.555~560 (2007)
- Liou MJ, "Renal metastasis from papillary thyroid microcarcinoma", Acta Otolaryngol, 125(4), pp.438~442 (2005)
- Ito Y, "Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid", World J Surg, 30(1), pp.91~99 (2006)
- Sipos JA, "Thyroid cancer epidemiology and prognostic variables", Clin Oncol (R Coll Radiol), 22(6), pp.395~404 (2010)
- Ito Y, "Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study", Endocr J, 59(5), pp.399~405 (2012)
- Cady B, "An expanded view of risk-group definition in differentiated thyroid carcinoma", Surgery, 104(6), pp.947~953 (1988)
- Sugitani I, "A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period", Surgery, 135(2), pp.139~148 (2004)
- Jin-Kyu Cho, "Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age", 대한외과학회지, 82(5), pp.281~287 (2012), 대한외과학회
- 김보연, "Impact of Clinicopathologic Factors on Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma", Yonsei Medical Journal, 53(5), pp.924~930 (2012), 연세대학교의과대학
- Roh JL, "Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection", Ann Surg Oncol, 15(4), pp.1177~1182 (2008)
- So YK, "Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections", Surgery, 148(3), pp.526~531 (2010)
- Kim SS, "Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis", Head Neck, 33(9), pp.1272~1277 (2011)
- )Schaffler A, "Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma", Eur J Clin Invest, 28(10), pp.838~844 (1998)
- Cooper DS, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19(11), pp.1167~1214 (2009)
- Loh KC, "Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma", J Clin Endocrinol Metab, 84(2), pp.458~463 (1999)
- Singh B, "Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome", Surgery, 126(6), pp.1070~1076 (1999)
- Shattuck TM, "Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma", N Engl J Med, 352(23), pp.2406~2412 (2005)
- Ito Y, "Papillary microcarcinoma of the thyroid: how should it be treated?", World J Surg, 28(11), pp.1115~1121 (2004)
- Ringel MD, "Controversies in the follow-up and management of well-differentiated thyroid cancer", Endocr Relat Cancer, 11(1), pp.97~116 (2004)
- Lee X, "Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma", Ann Surg Oncol, 16(2), pp.240~245 (2009)
- Pelizzo MR, "Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients", Eur J Surg Oncol, 32(10), pp.1144~1148 (2006)